EENT · PANCE / PANRE

Allergic Conjunctivitis

Written & clinically reviewed by Ryan Busch, PA-C · Updated August 2026 · Report an error

IgE-mediated bilateral ocular itching, redness, and watery discharge — frequently with allergic rhinitis.

Also known as: allergic conjunctivitis, seasonal allergic conjunctivitis, perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis

Overview

Bilateral IgE-mediated inflammation of the conjunctiva caused by environmental allergens. Forms: seasonal (SAC, pollen) and perennial (PAC, dust mite/animal/mold) — most common; vernal keratoconjunctivitis (VKC) — pediatric, atopic, severe with corneal involvement; atopic keratoconjunctivitis (AKC) — adult, chronic, sight-threatening; giant papillary conjunctivitis (GPC) — related to contact lenses or ocular prostheses.

Epidemiology

Affects 15-40% of the population in some form. Often coexists with allergic rhinitis, asthma, and eczema. VKC is most common in male children 5-15 in warm climates; AKC affects adults with atopic dermatitis.

Try two board-style Allergic Conjunctivitis questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1EENTMedium
A 22-year-old man with a history of asthma and eczema presents with 2 weeks of bilateral, intensely itchy, watery eyes every spring. He reports constant tearing and a stringy mucoid discharge, and says he cannot stop rubbing his eyes. He has had sneezing and nasal congestion during the same period. On slit-lamp examination there is diffuse conjunctival hyperemia, clear gelatinous swelling of the conjunctiva, and a papillary reaction on the tarsal conjunctiva; the cornea is clear. Which of the following best explains these findings?
  • AIgE cross-linking on mast cells releasing histamine and leukotrienes
  • BImmune complex deposition activating complement in the conjunctival tissue
  • CDirect epithelial cytotoxic injury from adenoviral viral replication
  • DDelayed T-cell hypersensitivity to an allergen on the eyelid skin
Reveal answer & full explanation
Correct answer: A — IgE cross-linking on mast cells releasing histamine and leukotrienes
  • AIgE cross-linking on mast cells releasing histamine and leukotrienes✓
  • BImmune complex deposition activating complement in the conjunctival tissue
  • CDirect epithelial cytotoxic injury from adenoviral viral replication
  • DDelayed T-cell hypersensitivity to an allergen on the eyelid skin

Why IgE cross-linking on mast cells releasing histamine and leukotrienes is correct

  • This is classic seasonal allergic conjunctivitis: bilateral itching (the hallmark), chemosis, watery/ropy discharge, and a papillary reaction in an atopic patient with concurrent allergic rhinitis.
  • The underlying mechanism is a Type I (immediate) hypersensitivity reaction: allergen cross-links IgE bound to conjunctival mast cells, triggering degranulation with histamine, tryptase, prostaglandins, and leukotrienes.
  • Histamine drives the early-phase itching, tearing, and redness within minutes; a late-phase eosinophil infiltrate hours later produces chemosis and persistent symptoms. This is why topical antihistamine/mast cell stabilizers (e.g., olopatadine) are first-line.

Why the others are wrong

  • Immune complex deposition activating complement in the conjunctival tissue: a Type III hypersensitivity mechanism that underlies conditions like serum sickness or vasculitis, not the immediate IgE-driven itching and chemosis seen here.
  • Delayed T-cell hypersensitivity to an allergen on the eyelid skin: a Type IV reaction seen in contact dermatitis of the eyelid (cosmetics, drops), which causes erythema and scaling of the lid skin over days, not acute bilateral conjunctival itching with chemosis.
  • Direct epithelial cytotoxic injury from adenoviral viral replication: the mechanism of viral conjunctivitis, which presents with watery discharge, a follicular reaction, preauricular adenopathy, and a recent URI; itching is mild and it is typically unilateral at onset.
Question 2EENTMedium
A 24-year-old woman presents in spring with 2 weeks of bilateral eye itching, tearing, and a stringy mucoid discharge. She rubs her eyes constantly and also reports sneezing and nasal congestion. She has a history of asthma and seasonal allergic rhinitis. On examination, visual acuity is normal, both conjunctivae are diffusely injected with clear gelatinous swelling, and there is no purulent discharge or preauricular adenopathy. Fluorescein staining shows no corneal uptake. Which of the following is the most appropriate initial management?
  • ATopical olopatadine
  • BTopical prednisolone
  • CTopical erythromycin
  • DTopical naphazoline
Reveal answer & full explanation
Correct answer: A — Topical olopatadine
  • ATopical olopatadine✓
  • BTopical prednisolone
  • CTopical erythromycin
  • DTopical naphazoline

Why Topical olopatadine is correct

  • Bilateral itching with chemosis, stringy mucoid discharge, and concurrent atopy (asthma, allergic rhinitis) is classic seasonal allergic conjunctivitis, an IgE-mediated mast cell process.
  • A topical dual-acting antihistamine/mast cell stabilizer such as olopatadine, ketotifen, or bepotastine is guideline-defined first-line pharmacotherapy: the antihistamine relieves acute itch while the mast cell stabilizer prevents ongoing degranulation, giving both rapid and sustained control.

Why the others are wrong

  • Topical prednisolone — a corticosteroid reserved as a short, ophthalmologist-supervised course for severe refractory flares; routine first-line use risks elevated IOP, cataract, and HSV reactivation.
  • Topical naphazoline — a vasoconstrictor decongestant that only whitens the eye and causes rebound hyperemia (conjunctivitis medicamentosa) with chronic use; it does not treat the allergic mechanism.
  • Topical erythromycin — an antibiotic for bacterial conjunctivitis (purulent discharge, matted lids), which this afebrile, itch-predominant, non-purulent presentation is not.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Allergic Conjunctivitis outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial → Sign in
Free to start · No credit card · Cancel anytime

Risk factors

  • Personal or family history of atopy (asthma, eczema, food allergy, allergic rhinitis)
  • Exposure to seasonal allergens (pollen) or year-round allergens (dust mite, mold, pet dander)
  • Contact lens wear (GPC)
  • Warm dry climate (VKC)
  • Childhood (VKC)

Pathophysiology

Allergen exposure cross-links IgE bound to conjunctival mast cells, causing degranulation with histamine, tryptase, prostaglandins, and leukotrienes. Early phase: itching, tearing, redness within minutes. Late phase: eosinophil infiltrate hours later → chemosis and persistent symptoms. VKC and AKC have additional Th2-driven chronic inflammation with eosinophils.

Clinical presentation

Symptoms

  • BILATERAL itching — the hallmark; 'I want to rub my eyes constantly'
  • Watery or stringy mucoid discharge
  • Redness, burning, foreign body sensation
  • Eyelid swelling and chemosis
  • Concurrent nasal symptoms (sneezing, congestion) — allergic rhinoconjunctivitis
  • Triggered by pollens, animal dander, dust

Signs / physical exam

  • Diffuse conjunctival hyperemia and chemosis (clear gelatinous swelling)
  • Papillary reaction on tarsal conjunctiva (giant papillae in VKC, AKC, GPC)
  • Watery or ropy mucus discharge
  • Mild eyelid edema
  • Allergic shiners
  • VKC: limbal Horner-Trantas dots, shield ulcer on cornea — sight-threatening
  • AKC: lichenified eyelid skin, keratoconus, cataracts in chronic disease

Classic findings

Bilateral itching with chemosis and watery stringy discharge in an atopic patient.

Differential diagnosis

  • Viral conjunctivitis — Watery discharge, preauricular adenopathy, recent URI, follicular reaction; itching mild
  • Bacterial conjunctivitis — Purulent discharge, eyelids matted shut, no itching
  • Dry eye disease — Burning, foreign body sensation, worse end of day, fluorescein punctate staining, low tear film breakup time; artificial tears, cyclosporine
  • Blepharitis — Eyelid margin scaling, telangiectasias, crusting; lid hygiene
  • Contact dermatitis of eyelid — Erythema and scaling of lid skin, history of allergen exposure (cosmetics, drops); topical steroid to lid
  • Toxic conjunctivitis — Recent topical drop or preservative exposure; resolves with cessation
  • Giant papillary conjunctivitis (GPC) — Contact lens wearer with itching, mucus, large papillae on upper tarsus; lens hygiene change

Diagnostic workup

Labs

  • Clinical diagnosis based on history and exam
  • Allergy testing (skin prick or specific IgE) if persistent or trigger unclear
  • Conjunctival scraping rarely needed — would show eosinophils

Imaging

  • Slit-lamp examination for chemosis, papillae, and corneal involvement
  • Fluorescein staining if corneal symptoms — exclude shield ulcer or punctate keratitis

Diagnostic algorithm

SubtypePopulationKey FeaturesRisk
Seasonal allergic conjunctivitis (SAC)Atopic, all agesPollen-triggered, itching, chemosisLow — symptomatic
Perennial allergic conjunctivitis (PAC)Year-round atopicDust mite/pet/mold-triggeredLow — symptomatic
Vernal keratoconjunctivitis (VKC)Boys 5-15, warm climateCobblestone tarsal papillae, Horner-Trantas dots, shield ulcerSight-threatening (shield ulcer, keratoconus)
Atopic keratoconjunctivitis (AKC)Adults with atopic dermatitisChronic, eyelid lichenification, corneal scarringSight-threatening; keratoconus, cataract
Giant papillary conjunctivitis (GPC)Contact lens wearersItching, mucus, giant tarsal papillaeLens intolerance
Subtypes of allergic conjunctivitis with distinguishing features and risk.

Treatment

First-line

  • Allergen avoidance — close windows during high pollen counts, wash hands and face after exposure, dust mite covers, pet dander measures
  • Cold compresses to reduce itching and swelling
  • Artificial tears (preservative-free preferred) to dilute and wash allergens
  • Topical ophthalmic antihistamine/mast cell stabilizer — olopatadine 0.1-0.7%, ketotifen 0.025%, alcaftadine, bepotastine — combined agents are first-line for moderate-severe disease
  • Topical mast cell stabilizer alone — cromolyn, lodoxamide, nedocromil — slower onset, useful prophylactically
  • Oral 2nd-generation antihistamine (loratadine, cetirizine, fexofenadine) if concurrent allergic rhinitis

Second-line / adjunct

  • Topical NSAIDs (ketorolac) — short-term symptom relief
  • Topical corticosteroids — short course (1-2 weeks) under ophthalmologist supervision for severe acute flares; monitor IOP and cataract formation
  • Topical calcineurin inhibitors (cyclosporine 0.05-0.1%, tacrolimus) — VKC/AKC and steroid-sparing chronic cases
  • Allergen immunotherapy (SCIT or SLIT) — particularly when concurrent allergic rhinitis warrants disease modification
  • Ophthalmology referral for VKC, AKC, shield ulcer, GPC unresponsive to lens change, or steroid dependence

Complications

  • Chronic eye rubbing → keratoconus (especially in VKC/AKC)
  • Corneal shield ulcer in VKC (sight-threatening)
  • Cataract and glaucoma from chronic topical steroid use
  • Secondary bacterial infection from rubbing
  • Reduced quality of life, sleep disruption, school/work impairment

PANCE pearls

  • BILATERAL ITCHING is the hallmark of allergic conjunctivitis — without itching, look elsewhere.
  • Topical olopatadine (antihistamine + mast cell stabilizer) is the workhorse — once-daily 0.7% formulation has good efficacy.
  • AVOID prolonged topical corticosteroids without ophthalmology supervision — cataract, glaucoma, and HSV reactivation risk.
  • Topical decongestant drops (naphazoline, tetrahydrozoline) cause rebound hyperemia with chronic use — discourage.
  • VKC and AKC are sight-threatening atopic phenotypes — refer to ophthalmology; treat eye rubbing to prevent keratoconus.
  • Contact lens wearer with itching + mucus + giant papillae = giant papillary conjunctivitis — change lens type/material or discontinue.

References

  • AAO 2018 — American Academy of Ophthalmology. Conjunctivitis Preferred Practice Pattern. Ophthalmology 2019;126(1):P94-P169
  • AAAAI 2020 — Bielory L et al. ICON: Diagnosis and Management of Allergic Conjunctivitis. Ann Allergy Asthma Immunol 2020;124(2):118-134

Practice EENT questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Commonly confused with

vs Bacterial Conjunctivitis

Related EENT diagnoses

Acute Otitis Media (AOM)Otitis Externa (Swimmer's Ear)Sensorineural and Conductive Hearing LossCerumen ImpactionAllergic RhinitisAcute Bacterial Rhinosinusitis (ABRS)Chronic Rhinosinusitis (CRS)EpistaxisGroup A Streptococcal PharyngitisPeritonsillar Abscess (Quinsy)Bacterial ConjunctivitisViral ConjunctivitisHordeolum (Stye) and ChalazionBlepharitis

Differentials & related conditions

Dry Eye Disease (Keratoconjunctivitis Sicca)

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.